Anzeige
Meldung des Tages: Gold auf 6.300 USD? Diese Aktie könnte der geheime Hebel sein

Curis News

Aktie
WKN:  A3ETJD ISIN:  US2312693094 US-Symbol:  CRIS Branche:  Biotechnologie Land:  USA
0,6631 $
+0,0382 $
+6,11%
0,5619 € 15.04.26
Depot/Watchlist
Marktkapitalisierung *
11,64 Mio. €
Streubesitz
57,31%
KGV
-0,42
Index-Zuordnung
-

Curis News

19.03.26 - PR Newswire
Curis Provides Fourth Quarter 2025 Business Update
Curis Provides Fourth Quarter 2025 Business Update PR Newswire
12.03.26 - PR Newswire
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026 PR Newswire
09.01.26 - PR Newswire
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds PR Newswire
07.01.26 - PR Newswire
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds PR Newswire
09.12.25 - PR Newswire
Curis Provides Updated Data from its Frontline AML Triplet Study
Curis Provides Updated Data from its Frontline AML Triplet Study PR Newswire
14.11.25 - PR Newswire
Curis to Present at Upcoming 30th Annual SNO Meeting
Curis to Present at Upcoming 30th Annual SNO Meeting PR Newswire
06.11.25 - PR Newswire
Curis Provides Third Quarter 2025 Business Update
Curis Provides Third Quarter 2025 Business Update PR Newswire
30.10.25 - PR Newswire
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 PR Newswire
03.10.25 - PR Newswire
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
02.09.25 - PR Newswire
Curis to Present at Upcoming Healthcare Conferences in September
Curis to Present at Upcoming Healthcare Conferences in September PR Newswire
05.08.25 - PR Newswire
Curis Provides Second Quarter 2025 Business Update
Curis Provides Second Quarter 2025 Business Update PR Newswire
29.07.25 - PR Newswire
Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025
Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025 PR Newswire
02.07.25 - PR Newswire
Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement
Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement PR Newswire
06.05.25 - PR Newswire
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
06.05.25 - PR Newswire
Curis Provides First Quarter 2025 Business Update
Curis Provides First Quarter 2025 Business Update PR Newswire
29.04.25 - PR Newswire
Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025 PR Newswire
02.04.25 - PR Newswire
Curis to Present at Upcoming Healthcare Conference in April
Curis to Present at Upcoming Healthcare Conference in April PR Newswire
31.03.25 - PR Newswire
Curis Provides Fourth Quarter 2024 Business Update
Curis Provides Fourth Quarter 2024 Business Update PR Newswire
28.03.25 - PR Newswire
Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025
Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 PR Newswire
10.12.24 - PR Newswire
Curis Announces Additional Data from TakeAim Leukemia Study
Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire

Newssuche

Videos

newspaper
07.04.26 0,00%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: VJ9H40 Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »